List of Excipients in API fingolimod hydrochloride
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing fingolimod hydrochloride
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 | FERRIC OXIDE YELLOW |
Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 | FERROSOFERRIC OXIDE |
Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 | GELATIN |
Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 | MAGNESIUM STEARATE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for fingolimod hydrochloride
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
fingolimod hydrochloride drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
>Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
fingolimod hydrochloride drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
>Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
fingolimod hydrochloride drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
>Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
fingolimod hydrochloride drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
>Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
fingolimod hydrochloride drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
>Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
fingolimod hydrochloride drug variants containing POTASSIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
>Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing POTASSIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
fingolimod hydrochloride drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
>Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
>Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
fingolimod hydrochloride drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
>Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
fingolimod hydrochloride drug variants containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
>Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
fingolimod hydrochloride drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
>Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.